The MANGUA Project: A Population-Based HIV Cohort in Guatemala

Table 1

Standardized variables collected in MANGUA.

Sociodemographic and behavioral variables	MANGUA study code, date of enrollment, gender, date of birth, country of origin, province of residence, ethnicity, religion, marital status, educational level, employment status, name of UAI, previous treatment, casualty date, casualty cause, cause of death, informed consent signed, vulnerability group, transmission group, probable year of infection, sexual orientation, and condom use.
Laboratory variables	Biochemistry and hematology variables, HIV rapid test, HIV ELISA test, serologies for toxoplasma, cytomegalovirus, histoplasma, cryptococcus, HBV, HCV, HSV, and syphilis. Sputum-smear microscopy for tuberculosis.
Clinical variables	WHO clinical stage, date of visit, type of visit, date of next scheduled visit, CD4 count, CD8 count, HIV RNA viral load, AIDS-related events, AIDS-defining events, and other coinfections.
Treatment variables	ART type, prophylaxis type, other treatments, initiation and stop date, reason for regime change, and adverse effects.

HBV: human hepatitis B virus; HCV: human hepatitis C virus; HSV: human herpes virus simplex types I and II. UAI: Unidad de atención integral; ELISA: enzyme-linked immunosorbent assay; RNA: ribonucleic acid; and ART: antiretroviral treatment.
For each type of treatment.